MXCT
MaxCyte, Inc.
NASDAQHealthcareMedical - DevicesUS
Rating:C+
Company Profile
CEO
Maher Masoud
IPO Date
2021-07-30
Sector
Healthcare
Industry
Medical - Devices
Exchange
NASDAQ
Country
US
MaxCyte, Inc.
CEO
Maher Masoud
IPO Date
2021-07-30
Sector
Healthcare
Industry
Medical - Devices
Exchange
NASDAQ
Country
US
| 375,000 |
| $0.68 |
| 10 Apr 2026 | Ahuja Parmeet | — | Disposed | 0 | $0.00 |
| 31 Mar 2026 | Masoud Maher | director, officer: President and CEO | A-Award | Acquired | 300,000 | $0.00 |
| 31 Mar 2026 | Masoud Maher | director, officer: President and CEO | A-Award | Acquired | 600,000 | $0.68 |
| 19 Mar 2026 | Swirsky Douglas J | CHIEF FINANCIAL OFFICER | S-Sale | Disposed | 10,142 | $0.81 |
| 27 Aug 2025 | Hemrajani Rekha | director | S-Sale | Disposed | 10,684 | $2.09 |
| 13 Aug 2025 | Swirsky Douglas J | CHIEF FINANCIAL OFFICER | P-Purchase | Acquired | 50,000 | $1.29 |
| 13 Aug 2025 | Masoud Maher | director, officer: President and CEO | P-Purchase | Acquired | 75,000 | $1.37 |
| 13 Aug 2025 | Erck Stanley C | director | P-Purchase | Acquired | 100,000 | $1.37 |